首页|体外膜肺氧合与连续性肾脏替代治疗联合治疗急性呼吸窘迫综合征的效果观察

体外膜肺氧合与连续性肾脏替代治疗联合治疗急性呼吸窘迫综合征的效果观察

扫码查看
目的 评估体外膜肺氧合(ECMO)与连续性肾脏替代治疗(CRRT)联合治疗急性呼吸窘迫综合征(ARDS)的效果。方法 选取2021年6月至2023年6月河南省人民医院收治的72例ARDS患者为研究对象。按照治疗方式的不同分成对照组与研究组,每组36例。对照组进行常规治疗,研究组在对照组治疗基础上加用ECMO与CRRT联合治疗。比较两组基本资料、氧合情况[动脉氧分压(PaO2)、动脉二氧化碳分压(PaCO2)、氧合指数、动脉血乳酸水平]、炎症指标[白细胞计数、降钙素原(PCT)、C-反应蛋白(CRP)]、急性生理和慢性健康评分Ⅱ(APACHE Ⅱ评分)以及治疗相关指标。结果 治疗前,两组PaO2、PaCO2、氧合指数及乳酸水平比较差异未见统计学意义(P>0。05);治疗3 d后,两组PaO2、氧合指数明显升高,PaCO2、动脉血乳酸水平显著降低,且研究组上述指标变化更明显,差异均有统计学意义(P<0。05)。治疗前,两组白细胞计数、PCT、CRP水平比较差异未见统计学意义(P>0。05);治疗3 d后,两组白细胞计数、PCT、CRP水平均明显降低,且研究组低于对照组,差异均有统计学意义(P<0。05)。治疗前,两组APACHE Ⅱ评分比较差异未见统计学意义(P>0。05);治疗3 d后,两组APACHE Ⅱ评分均显著下降,且研究组下降更明显,差异均有统计学意义(P<0。05)。研究组机械通气时间、ICU住院时间和总住院时间明显短于对照组,差异有统计学意义(P<0。05)。结论 ECMO联合CRRT治疗ARDS患者效果显著,能够改善氧合功能,减轻炎症反应,缩短机械通气时间,降低病死率,是一种安全有效的治疗策略。
Effect of extracorporeal membrane oxygenation combined with continuous renal replacement therapy on acute respiratory distress syndrome
Objective To evaluate the clinical effect of extracorporeal membrane oxygenation(ECMO)combined with continuous renal replacement therapy(CRRT)on patients with acute respiratory distress syndrome(ARDS).Methods Seventy-two ARDS patients admitted to Henan Provincial People's Hospital from June 2021 to June 2023 were selected as the research subjects.They were divided into a control group and a study group according to different treatment methods,with 36 cases in each group.The control group received routine treatment,while the study group received a combination of ECMO and CRRT in addition to the treatment in the control group.The basic data,oxygenation status(PaO2,PaCO2,oxygenation index,arterial lactate level),inflammatory indicators[leukocytes,procalcitonin(PCT),C-reactive protein(CRP)],acute physiological and chronic health score Ⅱ(APACHE Ⅱ score)and treatment-related indicators were compared between the two groups.Results Before treatment,there was no significant difference in PaO2,PaCO2,oxygenation index or lactate levels between the two groups(P>0.05).After 3 days of treatment,PaO2 and oxygenation index significantly increased in both groups,while PaCO2 and arterial blood lactate levels significantly decreased;moreover,the above indicators in the study group showed more significant changes,and the differences were significant(P<0.05).Before treatment,Before treatment,there was no significant difference in the levels of white blood cells,PCT or CRP between the two groups(P>0.05).After 3 days of treatment,the levels of white blood cells,PCT,and CRP in both groups were significantly reduced,and those of the study group were lower than those of the control group,with significant differences(P<0.05).Before treatment,there was no significant difference in APACHE Ⅱ scores between the two groups(P>0.05).After 3 days of treatment,both groups showed a significant decrease in APACHE Ⅱ scores,and the study group showed a more significant decrease,with significant differences(P<0.05).The mechanical ventilation time,ICU hospitalization time,and total hospitalization time of the study group were significantly shorter than those of the control group,and the differences were significant(P<0.05).Conclusions ECMO combined with CRRT is effective on ARDS patients,which can improve oxygenation function,reduce inflammatory response,shorten the duration of mechanical ventilation,and reduce mortality,which is a safe and effective treatment strategy.

Acute respiratory distress syndromeExtracorporeal membrane oxygenationContinuous renal replacement therapy

张萌萌、王海波、李云鹏

展开 >

河南省人民医院重症医学科 河南省危重病医学重点实验室 郑州市危重病医学重点实验室 郑州大学人民医院 河南大学人民医院,郑州 450003

急性呼吸窘迫综合征 体外膜肺氧合 连续性肾脏替代治疗

2024

临床医学
中华医学会河南分会

临床医学

影响因子:0.906
ISSN:1003-3548
年,卷(期):2024.44(2)
  • 12